Pulse 2.0
Cover art for Galvanize Therapeutics Raises $130 Million Series D

Galvanize Therapeutics Raises $130 Million Series D

Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform.

By ·

Nov 16, 2026

4 cards · 1m · tap to begin

From · · · 1m

Galvanize Therapeutics Raises $130 Million Series D

Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform.

In brief

Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform. Galvanize Therapeutics raised $130 million in Series D funding to commercialize its Aliya pulsed electric field platform and develop new applications in oncology and chronic disease. Originally reported by Pulse 2.0.

Funding Round

Galvanize Therapeutics closed an oversubscribed $130 million Series D financing to expand commercial business, generate clinical evidence, and develop pulsed electric field technologies.

Investors

HealthQuest Capital led the round with Olympus Innovation Ventures and Braidwell joining existing backers including Sofinnova Partners, Norwest, Elevage Medical Technologies, Ally Bridge Group, Perceptive Advisors, Janus Henderson Investors, Longaeva Partners, Fidelity Management & Research…

Leadership

HealthQuest Founder and Managing Partner Dr. Garheng Kong will join Galvanize’s board to support the company’s growth strategy.

Commercial Progress

The company commercializes its Aliya pulsed electric field platform in the United States while developing applications in oncology and chronic disease.

What matters most

Galvanize Therapeutics raised $130 million in Series D funding to commercialize its Aliya pulsed electric field platform and develop new applications in oncology and chronic disease.

Read the original on Pulse 2.0

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on galvanize therapeutics and related topics.